Ultragenyx Stock In The News

RARE Stock  USD 41.62  0.82  2.01%   
Our overall analysis of Ultragenyx's news coverage and content from conventional and social sources shows investors' bearish mood towards Ultragenyx. The specific impact of Ultragenyx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ultragenyx's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ultragenyx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ultragenyx Backtesting and Ultragenyx Hype Analysis.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Ultragenyx to Participate at Investor Conferences in March
https://www.globenewswire.com/news-release/2025/02/24/3031559/20739/en/Ultragenyx-to-Participate-at-Investor-Conferences-in-March.html
 Bullish
Yahoo News
Ultragenyx to Participate at Investor Conferences in March
https://finance.yahoo.com/news/ultragenyx-participate-investor-conferences-march-213000268.html
 Bullish
Yahoo News
Exploring Three High Growth Tech Stocks in the United States
https://finance.yahoo.com/news/exploring-three-high-growth-tech-180204161.html
 Bullish
Macroaxis News: globenewswire.com
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2025/02/19/3029195/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Yahoo News
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/ultragenyx-reports-inducement-grant-under-213000621.html
 Bullish
reuters
USDA will not ban cattle imports from Mexico over latest screwworm case, agency says
https://www.reuters.com/business/healthcare-pharmaceuticals/usda-will-not-ban-cattle-imports-mexico-over-latest-screwworm-case-agency-says-2025-02-18/
 Bearish
Yahoo News
Ultragenyx Announces FDA Acceptance and ...
https://finance.yahoo.com/news/ultragenyx-announces-fda-acceptance-priority-130000271.html
 Neutral
reuters
Baidu share slide wipes $2.4 billion off market value amid speculation over Xi meeting
https://www.reuters.com/technology/baidu-share-slide-wipes-24-billion-off-market-value-amid-speculation-over-xi-2025-02-17/
 Bullish
Yahoo News
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
https://finance.yahoo.com/news/ultragenyx-pharmaceutical-inc-nasdaq-rare-140241375.html
 Neutral
reuters
Banks sell down more X debt; just $1.3bln now left on their books
https://www.reuters.com/business/finance/banks-sell-down-more-x-debt-just-13bln-now-left-their-books-2025-02-14/
 Neutral

Ultragenyx Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ultragenyx and other traded companies coverage with news coverage. We help investors stay connected with Ultragenyx headlines for the 26th of February to make an informed investment decision based on correlating the impacts of news items on Ultragenyx Stock performance. Please note that trading solely based on the Ultragenyx hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ultragenyx's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ultragenyx investors visualize upcoming and past events in order to time the market based on Ultragenyx noise-free hype analysis.
Ultragenyx stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ultragenyx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ultragenyx that are available to investors today. That information is available publicly through Ultragenyx media outlets and privately through word of mouth or via Ultragenyx internal channels. However, regardless of the origin, that massive amount of Ultragenyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ultragenyx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ultragenyx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ultragenyx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ultragenyx alpha.

Ultragenyx Largest EPS Surprises

Earnings surprises can significantly impact Ultragenyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-05-11
2015-03-31-0.54-0.63-0.0916 
2020-10-27
2020-09-30-1.26-1.130.1310 
2015-11-09
2015-09-30-0.87-1.03-0.1618 
2024-08-01
2024-06-30-1.69-1.520.1710 
2019-08-01
2019-06-30-1.7-1.89-0.1911 
2015-08-13
2015-06-30-0.63-0.83-0.231 
View All Earnings Estimates

Ultragenyx Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ultragenyx Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
25th of February 2025
Ultragenyx Pharmaceutical Inc Announces Participation in Upcoming Investor Conferences
at gurufocus.com 
Macroaxis News: globenewswire.com
19th of February 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635
at globenewswire.com 
Gurufocus Stories at Macroaxis
18th of February 2025
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Applicati...
at gurufocus.com 
Yahoo News
14th of February 2025
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase YY
at finance.yahoo.com 
Yahoo News
13th of February 2025
Ultragenyx Q4 Earnings Taking a Look at Key Metrics Versus Estimates
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
10th of February 2025
Wellington Management Group LLP Reduces Stake in Ultragenyx Pharmaceutical Inc
at gurufocus.com 
zacks News
22nd of January 2025
Rhythm Pharmaceuticals Soars 5.5 percent Is Further Upside Left in the Stock
at zacks.com 
Yahoo News
6th of January 2025
European Commission Extends the Approval of Evkeeza to Children as Young as 6-months Old w...
at finance.yahoo.com 
news
13th of December 2024
Y Intercept Hong Kong Ltd Buys 12,617 Shares of Ultragenyx Pharmaceutical Inc.
at thelincolnianonline.com 

Ultragenyx Investors Sentiment

The influence of Ultragenyx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ultragenyx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ultragenyx's public news can be used to forecast risks associated with an investment in Ultragenyx. The trend in average sentiment can be used to explain how an investor holding Ultragenyx can time the market purely based on public headlines and social activities around Ultragenyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ultragenyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ultragenyx's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ultragenyx's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ultragenyx.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ultragenyx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ultragenyx's short interest history, or implied volatility extrapolated from Ultragenyx options trading.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out Ultragenyx Backtesting and Ultragenyx Hype Analysis.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.29)
Revenue Per Share
6.188
Quarterly Revenue Growth
0.294
Return On Assets
(0.22)
Return On Equity
(2.12)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.